GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (OTCPK:SGIOF) » Definitions » Cyclically Adjusted PS Ratio

Shionogi (Shionogi) Cyclically Adjusted PS Ratio : 6.24 (As of Apr. 30, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shionogi Cyclically Adjusted PS Ratio?

As of today (2024-04-30), Shionogi's current share price is $49.60. Shionogi's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $7.95. Shionogi's Cyclically Adjusted PS Ratio for today is 6.24.

The historical rank and industry rank for Shionogi's Cyclically Adjusted PS Ratio or its related term are showing as below:

SGIOF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.61   Med: 6.41   Max: 8.4
Current: 6.25

During the past years, Shionogi's highest Cyclically Adjusted PS Ratio was 8.40. The lowest was 4.61. And the median was 6.41.

SGIOF's Cyclically Adjusted PS Ratio is ranked worse than
86.2% of 739 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs SGIOF: 6.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shionogi's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.557. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $7.95 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shionogi Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Shionogi's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Cyclically Adjusted PS Ratio Chart

Shionogi Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.23 5.46 6.09 7.41 5.43

Shionogi Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.03 5.43 5.40 5.80 5.81

Competitive Comparison of Shionogi's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shionogi's Cyclically Adjusted PS Ratio falls into.



Shionogi Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shionogi's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=49.60/7.95
=6.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Shionogi's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.557/106.8000*106.8000
=2.557

Current CPI (Dec. 2023) = 106.8000.

Shionogi Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.089 95.700 2.331
201406 1.835 98.000 2.000
201409 1.864 98.500 2.021
201412 1.767 97.900 1.928
201503 1.852 97.900 2.020
201506 1.561 98.400 1.694
201509 1.873 98.500 2.031
201512 2.179 98.100 2.372
201603 2.252 97.900 2.457
201606 2.100 98.100 2.286
201609 2.435 98.000 2.654
201612 2.681 98.400 2.910
201703 2.252 98.100 2.452
201706 2.088 98.500 2.264
201709 2.708 98.800 2.927
201712 2.497 99.400 2.683
201803 2.400 99.200 2.584
201806 2.521 99.200 2.714
201809 2.232 99.900 2.386
201812 2.763 99.700 2.960
201903 2.964 99.700 3.175
201906 2.398 99.800 2.566
201909 2.471 100.100 2.636
201912 2.707 100.500 2.877
202003 2.398 100.300 2.553
202006 2.183 99.900 2.334
202009 2.351 99.900 2.513
202012 2.372 99.300 2.551
202103 2.207 99.900 2.359
202106 2.077 99.500 2.229
202109 2.291 100.100 2.444
202112 2.171 100.100 2.316
202203 3.230 101.100 3.412
202206 1.778 101.800 1.865
202209 1.832 103.100 1.898
202212 4.705 104.100 4.827
202303 2.245 104.400 2.297
202306 2.627 105.200 2.667
202309 2.800 106.200 2.816
202312 2.557 106.800 2.557

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shionogi  (OTCPK:SGIOF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shionogi Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Shionogi's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi (Shionogi) Business Description

Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (Shionogi) Headlines

From GuruFocus

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research 02-14-2024

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research 02-14-2024